statistiche ricercatore

Continente	#
AS - Asia	481
NA - Nord America	462
EU - Europa	290
SA - Sud America	49
Continente sconosciuto - Info sul continente non disponibili	25
AF - Africa	13
OC - Oceania	1
Totale	1.321

Nazione	#
US - Stati Uniti d'America	443
SG - Singapore	198
CN - Cina	109
IT - Italia	98
HK - Hong Kong	46
VN - Vietnam	37
FR - Francia	35
BR - Brasile	33
KR - Corea	32
NL - Olanda	28
GB - Regno Unito	27
DE - Germania	24
BD - Bangladesh	18
FI - Finlandia	16
SE - Svezia	15
PL - Polonia	13
RU - Federazione Russa	12
TR - Turchia	10
IN - India	7
CH - Svizzera	6
AT - Austria	5
MA - Marocco	4
MX - Messico	4
ZA - Sudafrica	4
AR - Argentina	3
CA - Canada	3
EC - Ecuador	3
IE - Irlanda	3
JP - Giappone	3
AZ - Azerbaigian	2
CL - Cile	2
GE - Georgia	2
GR - Grecia	2
ID - Indonesia	2
MO - Macao, regione amministrativa speciale della Cina	2
NI - Nicaragua	2
PE - Perù	2
PH - Filippine	2
SA - Arabia Saudita	2
TW - Taiwan	2
UY - Uruguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
BB - Barbados	1
BF - Burkina Faso	1
BH - Bahrain	1
BO - Bolivia	1
CO - Colombia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DM - Dominica	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
GT - Guatemala	1
HN - Honduras	1
IL - Israele	1
IQ - Iraq	1
JM - Giamaica	1
KG - Kirghizistan	1
MQ - Martinica	1
MY - Malesia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PK - Pakistan	1
PR - Porto Rico	1
RO - Romania	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
TZ - Tanzania	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.297

Nome	#
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies	194
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey	180
Grey zones in the supportive treatments of cardiac amyloidosis	171
Clinical Use of Biomarkers in Cardiac Amyloidosis	158
Re-Definition of the Epidemiology of Cardiac Amyloidosis	148
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis	127
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis	117
Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis	105
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study	72
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy	49
Totale	1.321

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	59	0	6	4	9	11	7	2	3	9	0	8	0
2023/2024	115	8	5	3	7	5	10	23	10	1	1	7	35
2024/2025	316	8	12	35	22	32	22	11	15	20	63	29	47
2025/2026	738	60	47	72	62	38	58	95	37	103	89	49	28
2026/2027	93	40	33	20	0	0	0	0	0	0	0	0	0
Totale													1.321

ArTS Archivio della ricerca di Trieste